Patents Assigned to GLYKOS BIOMEDICAL OY
  • STABILE CONJUGATE
    Publication number: 20230038373
    Abstract: A conjugate is disclosed. The conjugate may be represented by Formula I: [D-G-L]n-T Formula I wherein D is a payload molecule; O is an oxygen atom of said payload molecule; T is a targeting unit capable of binding a target molecule, cell and/or tissue; and n is at least 1.
    Type: Application
    Filed: December 18, 2020
    Publication date: February 9, 2023
    Applicant: Glykos Biomedical OY
    Inventors: Tero SATOMAA, Juhani SAARINEN, Jari HELIN, Olli AITIO, Henna PYNNÖNEN
  • CONJUGATE
    Publication number: 20210402002
    Abstract: A conjugate is disclosed. The conjugate may comprise a targeting unit for delivery to a tumour, and a glycosylation inhibitor for inhibiting glycosylation in the tumour, thereby decreasing the immunosuppressive activity of the tumour. The glycosylation inhibitor may be conjugated to the targeting unit.
    Type: Application
    Filed: June 19, 2019
    Publication date: December 30, 2021
    Applicant: GLYKOS BIOMEDICAL OY
    Inventors: Juhani SAARINEN, Tero SATOMAA, Olli AITIO
  • CONJUGATES
    Publication number: 20210138080
    Abstract: A conjugate is disclosed. The conjugate may comprise a targeting unit for delivery to a target tissue, and a Galectin inhibitor for inhibiting Galectin interaction within the target tissue, wherein the Galectin inhibitor is conjugated to the targeting unit.
    Type: Application
    Filed: June 19, 2019
    Publication date: May 13, 2021
    Applicant: GLYKOS BIOMEDICAL OY
    Inventors: Tero SATOMAA, Juhani SAARINEN